Hypoglycaemia downregulates endotoxin-induced production of tumour necrosis factor-α, but does not affect IL-1β, IL-6, or IL-10

被引:14
作者
de Galan, BE
Netea, MG
Smits, P
van der Meer, JWM
机构
[1] Univ Nijmegen, Med Ctr, Dept Gen Internal Med, Nijmegen, Netherlands
[2] Univ Nijmegen, Med Ctr, Dept Pharmacol Toxicol, Nijmegen, Netherlands
关键词
diabetes mellitus; humans; hypoglycaemia; insulin; TNF alpha;
D O I
10.1016/S1043-4666(03)00113-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The aim of the present study was to investigate the effect of hypoglycaemia on the production capacity of the proinflammatory cytokines tumour necrosis factor-alpha (TNFalpha) and interleukin-1beta (IL-1beta) in subjects with and without diabetes. Hyperinsulinaemic (360 pmol m(-2) min(-1)) stepped hypoglycaemic (5.0-3.5-2.5 mmol 1(-1)) glucose clamps were performed in eight diabetic patients and in six non-diabetic subjects, and hyperinsulinaemic normoglycaemia (5.0 mmol 1(-1)) control experiments were performed in four nondiabetic subjects. Circulating levels of cytokines and endotoxin-induced production of TNFalpha, IL-1beta IL-6, and IL-10 were assessed. The effects of insulin and adrenaline were measured in separate in vitro experiments. In non-diabetic subjects, hypoglycaernia downregulated the production capacity of TNFalpha in a concentration-dependent fashion (P = 0.007), but not of IL-1beta, IL-6, or IL-10. Compared to controls, the production capacity of TNFalpha in diabetic patients was already suppressed at normoglycaernia (P = 0.02) and only fell in response to hypoglycaemic nadir (P = 0.04). The downregulation of TNFalpha could not be explained by increased insulin or adrenaline levels. We conclude that hypoglycaemia specifically downregulates TNFalpha production capacity. Diabetic patients already have a suppressed TNFalpha production capacity at non-hypoglycaemic levels. (C) 2003 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:71 / 76
页数:6
相关论文
共 29 条
[1]  
BOGDAN C, 1992, J BIOL CHEM, V267, P23301
[2]   HYPOGLYCEMIA - THE LIMITING FACTOR IN THE MANAGEMENT OF IDDM [J].
CRYER, PE .
DIABETES, 1994, 43 (11) :1378-1389
[3]   Theophylline improves hypoglycemia unawareness in type 1 diabetes [J].
de Galan, BE ;
Tack, CJ ;
Lenders, JW ;
Pasman, JW ;
Elving, LD ;
Russel, FG ;
Lutterman, JA ;
Smits, P .
DIABETES, 2002, 51 (03) :790-796
[4]   ENDURANCE RUN INCREASES CIRCULATING IL-6 AND IL-1RA BUT DOWN-REGULATES EX-VIVO TNF-ALPHA AND IL-1-BETA PRODUCTION [J].
DRENTH, JPH ;
VANUUM, SHM ;
VANDEUREN, M ;
PESMAN, GJ ;
VANDERVENJONGEKRIJG, J ;
VANDERMEER, JWM .
JOURNAL OF APPLIED PHYSIOLOGY, 1995, 79 (05) :1497-1503
[5]   INTERLEUKIN-2 AND SOLUBLE INTERLEUKIN-2 RECEPTOR SECRETION DEFECT INVITRO IN NEWLY DIAGNOSED TYPE-I DIABETIC-PATIENTS [J].
GIORDANO, C ;
PANTO, F ;
CARUSO, C ;
MODICA, MA ;
ZAMBITO, AM ;
SAPIENZA, N ;
AMATO, MP ;
GALLUZZO, A .
DIABETES, 1989, 38 (03) :310-315
[6]  
GRANOWITZ EV, 1993, J IMMUNOL, V151, P1637
[7]  
Hancu N, 1998, Rom J Physiol, V35, P325
[8]   SLOWING OF WOUND-HEALING BY PSYCHOLOGICAL STRESS [J].
KIECOLTGLASER, JK ;
MARUCHA, PT ;
MALARKEY, WB ;
MERCADO, AM ;
GLASER, R .
LANCET, 1995, 346 (8984) :1194-1196
[9]  
LAHAT N, 1992, CLIN EXP IMMUNOL, V89, P255
[10]   SURGERY, TRAUMA AND IMMUNE SUPPRESSION - EVOLVING THE MECHANISM [J].
LUNDY, J ;
FORD, CM .
ANNALS OF SURGERY, 1983, 197 (04) :434-438